OUTPACE BIO Trademark

Trademark Overview

On Friday, September 11, 2020, a trademark application was filed for OUTPACE BIO with the United States Patent and Trademark Office. The USPTO has given the OUTPACE BIO trademark a serial number of 90173877. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, January 23, 2025. This trademark is owned by Outpace Bio, Inc.. The OUTPACE BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy
outpace bio

General Information

Serial Number90173877
Word MarkOUTPACE BIO
Filing DateFriday, September 11, 2020
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, January 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements

Pseudo MarkOUT PACE BIO
NOT AVAILABLE"BIO"
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code042
First Use Anywhere DateMonday, November 16, 2020
First Use In Commerce DateMonday, November 16, 2020

Trademark Owner History

Party NameOutpace Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameOutpace Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Tuesday, September 15, 2020NEW APPLICATION ENTERED
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 22, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2021NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 6, 2021FINAL REFUSAL WRITTEN
Tuesday, July 6, 2021FINAL REFUSAL E-MAILED
Tuesday, July 6, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 6, 2021EXAMINERS AMENDMENT E-MAILED
Friday, August 6, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 6, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, August 6, 2021EXAMINER'S AMENDMENT ENTERED
Friday, August 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 10, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 20, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 20, 2022SOU EXTENSION 1 FILED
Wednesday, April 20, 2022SOU EXTENSION 1 GRANTED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 7, 2022SOU EXTENSION 2 FILED
Monday, November 7, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 3 FILED
Tuesday, May 2, 2023SOU EXTENSION 3 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 4 FILED
Monday, November 6, 2023SOU EXTENSION 4 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024SOU EXTENSION 5 GRANTED
Thursday, May 2, 2024SOU EXTENSION 5 FILED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2024USE AMENDMENT FILED
Friday, November 8, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, January 23, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, January 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

outpace development pharmaceutical drugs preparations research field diseases scientific disorders therapy